clinical 1,707 words KG: ent-clin-c237937a 2026-03-28
kind:clinical-trialsection:clinical-trialstopic:alzheimerstopic:diabetestopic:glp-1-agonisttopic:phase-3
Contents

GLP-1/GCG Dual Agonist LIGHT-COG (NCT07083154)

Knowledge Graph

Related Hypotheses (9)

APOE-Dependent Autophagy Restoration
Score: 0.61
Dual-Domain Antibodies with Engineered Fc-FcRn Affinity Modu
Score: 0.57
Near-infrared light therapy stimulates COX4-dependent mitoch
Score: 0.51
Metabolic Switch Targeting for A1→A2 Repolarization
Score: 0.48
Purinergic P2Y12 Inverse Agonist Therapy
Score: 0.48

Related Analyses (4)

Metabolic reprogramming in neurodegenerative disease
neurodegeneration · completed
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived
Synaptic pruning by microglia in early AD
neurodegeneration · archived
Mitochondrial transfer between astrocytes and neurons
neurodegeneration · archived

Related Experiments (9)

GLP-1 Agonist Neuroprotection Mechanism in PD
clinical · proposed · Score: 0.40
GLP-1 Agonist Responder Prediction Study — Precision Medicin
clinical · proposed · Score: 0.40
Metabolic Syndrome-Parkinson's Disease Axis Clinical Trial
clinical · proposed · Score: 0.40
Tirzepatide vs Semaglutide Anti-Atherosclerotic Effects in A
validation · proposed · Score: 0.90
AAV-LRRK2 IND-Enabling Study Design
clinical · proposed · Score: 0.40